Ikarian Capital, LLC
Q1 2025 13F Holdings
- Locationdallas, TX
- Num holdings
160
- Value ($000)
$811,473
- Date Filed05/15/2025
- Form type13F-HR
- CIK0001778253
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
SPY SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | $179.00M | 22 % | 320,000 | put | |
LLY ELI LILLY & CO | COM | 532457108 | $123.89M | 15 % | 150,000 | put | |
HTD CORCEPT THERAPEUTICS INC | COM | 218352102 | $32.88M | 4 % | 287,900 | put | |
TARS TARSUS PHARMACEUTICALS INC | COM | 87650L103 | $24.92M | 3 % | 485,021 | ||
BBIO BRIDGEBIO PHARMA INC | COM | 10806X102 | $22.66M | 3 % | 655,400 | call | |
CRNX CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | $17.56M | 2 % | 523,431 | ||
SOLENO THERAPEUTICS INC | COM | 834203309 | $17.36M | 2 % | 243,000 | call | |
SPY SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | $13.98M | 2 % | 25,000 | ||
HTD CORCEPT THERAPEUTICS INC | COM | 218352102 | $11.42M | 1 % | 100,000 | call | |
SRPT SAREPTA THERAPEUTICS INC | COM | 803607100 | $10.79M | 1 % | 169,087 |
Rows Per Page
10
- 10
- 50
- 100